ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	29/276	79/7206	1.1514818249e-21
ko04510	Focal adhesion	40/276	240/7206	1.03829960718e-15
ko04151	PI3K-Akt signaling pathway	51/276	390/7206	2.72688447023e-15
ko04974	Protein digestion and absorption	25/276	96/7206	8.52574768305e-15
ko04060	Cytokine-cytokine receptor interaction	30/276	191/7206	2.50141621855e-11
ko05200	Pathways in cancer	49/276	492/7206	3.03414357529e-10
ko04933	AGE-RAGE signaling pathway in diabetic complications	21/276	135/7206	3.35724168217e-08
ko05146	Amoebiasis	17/276	99/7206	1.63312148914e-07
ko04810	Regulation of actin cytoskeleton	28/276	264/7206	7.95946167286e-07
ko05205	Proteoglycans in cancer	27/276	271/7206	4.24916228447e-06
ko05410	Hypertrophic cardiomyopathy (HCM)	15/276	100/7206	5.1698584806e-06
ko04668	TNF signaling pathway	16/276	120/7206	1.18864166192e-05
ko05166	HTLV-I infection	27/276	292/7206	2.57705667922e-05
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	12/276	79/7206	4.04894933149e-05
ko04658	Th1 and Th2 cell differentiation	13/276	96/7206	6.70977544325e-05
ko05414	Dilated cardiomyopathy	14/276	112/7206	8.65217148581e-05
ko05222	Small cell lung cancer	12/276	89/7206	0.000133378923341
ko04218	Cellular senescence	18/276	177/7206	0.000137631196572
ko04350	TGF-beta signaling pathway	13/276	103/7206	0.000139994822026
ko04380	Osteoclast differentiation	15/276	134/7206	0.000172839062664
ko05321	Inflammatory bowel disease (IBD)	9/276	56/7206	0.000242256641765
ko05145	Toxoplasmosis	14/276	126/7206	0.000306888904286
ko05224	Breast cancer	17/276	174/7206	0.000340662765502
ko04310	Wnt signaling pathway	17/276	181/7206	0.000540324832873
ko04015	Rap1 signaling pathway	23/276	278/7206	0.000578960520005
ko04640	Hematopoietic cell lineage	9/276	64/7206	0.000673767149702
ko05131	Shigellosis	10/276	82/7206	0.00107772286369
ko05142	Chagas disease (American trypanosomiasis)	13/276	130/7206	0.00136002768277
ko05144	Malaria	7/276	45/7206	0.00145694281034
ko04659	Th17 cell differentiation	11/276	106/7206	0.00233873410197
ko04390	Hippo signaling pathway	16/276	188/7206	0.00280639409596
ko04916	Melanogenesis	13/276	142/7206	0.00300665992333
ko05161	Hepatitis B	15/276	173/7206	0.00359544421763
ko04010	MAPK signaling pathway	23/276	321/7206	0.00402483265872
ko05206	MicroRNAs in cancer	15/276	177/7206	0.00406002151088
ko05212	Pancreatic cancer	9/276	83/7206	0.0042707543507
ko04611	Platelet activation	14/276	163/7206	0.00538855347803
ko05210	Colorectal cancer	9/276	86/7206	0.00540923709755
ko04657	IL-17 signaling pathway	9/276	87/7206	0.00583677851891
ko04068	FoxO signaling pathway	14/276	167/7206	0.0060726896568
ko04014	Ras signaling pathway	20/276	279/7206	0.00617809485642
ko05323	Rheumatoid arthritis	9/276	89/7206	0.00676975326119
ko00643	Styrene degradation	2/276	4/7206	0.00833282263898
ko04621	NOD-like receptor signaling pathway	13/276	157/7206	0.00907682997629
ko04672	Intestinal immune network for IgA production	5/276	37/7206	0.01269150363
ko05220	Chronic myeloid leukemia	8/276	85/7206	0.0157111897085
ko04144	Endocytosis	22/276	342/7206	0.0194277640316
ko04360	Axon guidance	16/276	233/7206	0.022193818996
ko04660	T cell receptor signaling pathway	10/276	124/7206	0.0277960208294
ko04142	Lysosome	1/276	151/7206	0.0312940285996
ko05202	Transcriptional misregulation in cancer	13/276	188/7206	0.0331877334889
ko05230	Central carbon metabolism in cancer	7/276	81/7206	0.0349481279095
ko05219	Bladder cancer	5/276	48/7206	0.0355486806347
ko00350	Tyrosine metabolism	4/276	33/7206	0.0359956358088
ko05034	Alcoholism	3/276	238/7206	0.0367619906649
ko04931	Insulin resistance	10/276	137/7206	0.0415399446004
ko05418	Fluid shear stress and atherosclerosis	12/276	173/7206	0.0420212556977
ko05217	Basal cell carcinoma	6/276	68/7206	0.0451134458398
ko05133	Pertussis	7/276	87/7206	0.048533500559